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Abstract The distribution of fitness effects (DFE) defines how new mutations spread through an
evolving population. The ratio of non-synonymous to synonymous mutations (dN/dS) has become a
popular method to detect selection in somatic cells. However the link, in somatic evolution,
between dN/dS values and fitness coefficients is missing. Here we present a quantitative model of
somatic evolutionary dynamics that determines the selective coefficients of individual driver
mutations from dN/dS estimates. We then measure the DFE for somatic mutant clones in
ostensibly normal oesophagus and skin. We reveal a broad distribution of fitness effects, with the
largest fitness increases found for TP53 and NOTCH1 mutants (proliferative bias 1–5%). This study
provides the theoretical link between dN/dS values and selective coefficients in somatic evolution,
and measures the DFE of mutations in human tissues.
Introduction
One of the principal goals of large-scale genome sequencing of somatic tissues is to uncover genetic
loci under positive selection, so-called ‘driver’ genes, that lead to clonal expansions. Measurement
of the selective advantage of each driver mutation enables prediction of future evolutionary dynam-
ics (Williams et al., 2019), provided the selective regime remains constant. In evolutionary biology,
the distribution of fitness effects (DFE) is a fundamental entity that describes the selective conse-
quences of a (large) number of individual mutations of an ancestral genome (Eyre-Walker and
Keightley, 2007). In somatic evolution, particularly in cancer genomes, we have an extensive knowl-
edge of the catalogue of recurrent, and likely positively selected, somatic mutations
(Martincorena et al., 2017), but the fitness changes associated with each mutation remain largely
unquantified.
Extensive experimental effort is ongoing to determine the fitness effects of mutations. Most
prominently is lineage tracing of mutations in mouse models (Vermeulen et al., 2013; Rogers et al.,
2018), but these methods are not sufficiently high-throughput to produce the DFE for all somatic
mutations. Other studies have estimated the selective coefficient of somatic mutations by measuring
their frequency over time in the same individual using longitudinal sampling (Ko¨rber et al., 2019),
however this method is broadly limited to somatic evolution in the blood (Gibson and Steensma,
Williams et al. eLife 2020;9:e48714. DOI: https://doi.org/10.7554/eLife.48714 1 of 19
RESEARCH ARTICLE
2018) (where it is feasible to take samples from healthy individuals over time) and in rare cases of
patients under active surveillance.
An alternative approach is to infer selective coefficients directly from genome sequencing data.
Methods to identify positively-selected (driver) mutations rely on finding genes that have significantly
more mutational ‘hits’ (typically hits are non-synonymous mutations) than would be expected by
chance, after correction for factors known to influence the mutation rate across the genome
(Bailey et al., 2018). Conversely, negatively selected genes are expected to show a paucity of muta-
tions (Weghorn and Sunyaev, 2017; Zapata et al., 2018). This idea is formalised in the calculation
of the dN/dS ratio – a method originally developed in molecular species evolution – that has recently
been adapted to study somatic evolution (both cancer and normal tissue) (Martincorena et al.,
2017; Weghorn and Sunyaev, 2017; Zapata et al., 2018; Wu et al., 2016; Greenman et al., 2006;
Yang et al., 2003; Martincorena et al., 2018; Lee-Six et al., 2018). The intuitive idea behind dN/dS
is to measure the rate of non-synonymous (dN) mutations (possibly under selection) and compare
that to the rate of synonymous (dS) mutations (presumed neutral). The ratio of these two numbers,
each normalised for the local sequence-specific biases in the mutation rate, putatively identifies a
signature of selection: dN/dS >1 indicating positive selection, dN/dS = 1 indicating neutral evolution
and dN/dS <1 indicating negative selection.
Transforming dN/dS values to selective coefficients in somatic evolution is an unaddressed prob-
lem. dN/dS was originally developed in the context of species evolution using the Wright-Fisher pro-
cess, a classical population genetics model that assumes that evolution occurs over very long
timescales, which permits new mutations to fix within lineages. The Wright-Fisher model assumes
constant population sizes, non-overlapping generations and that all individuals have equal potency.
Under the Wright-Fisher model, the dN/dS of a locus is related to its selective coefficient by the rela-
tion (Nielsen and Yang, 2003):
dN
dS
¼
2Ns
1  e 2Ns
Where N is the effective population size and s the selection coefficient.
However, in somatic evolution the assumptions of the Fisher-Wright model are violated. Somatic
evolution is rapid and new mutations are infrequently fixed in the population (McGranahan and
Swanton, 2017), clonal dynamics are complex (Williams et al., 2019), and population sizes unlikely
to be constant (Sottoriva et al., 2015). Further, the lack of recombination in somatic evolution can
result in strong hitchhiking effects (Tilk et al., 2019). In addition, since in somatic evolution, the
ancestral genome is known, the need to measure dN/dS across a phylogeny is circumvented (a nec-
essary step for dN/dS analysis in species evolution). Violations of some of these assumptions was
previously recognised to make the interpretation of dN/dS problematic (Kryazhimskiy and Plotkin,
2008; Mugal et al., 2014), and consequently the relationship between selective coefficients and
dN/dS values is uncertain.
The size distribution of clones (called the site frequency spectrum in population genetics nomen-
clature) also contains information on the selective coefficients of newly arising mutations. Mathemati-
cal descriptions of the dynamics of populations of cells can make predictions on the shape of the
clone size distribution under different demographic and evolutionary models (Simons, 2016a; Dur-
rett, 2013). This approach has been used to quantify the dynamics and cell fate properties of stem
cells across many tissues in model systems (Klein et al., 2010; Lopez-Garcia et al., 2010;
Vermeulen et al., 2013). We and others have also used similar approaches applied to deep
sequencing data to infer the evolutionary dynamics of tumours (Williams et al., 2016;
Williams et al., 2018; Bozic et al., 2016; Ling et al., 2015) and of clonal haematopoiesis in the
blood (Watson et al., 2019).
To date, dN/dS analysis and the analysis of the clone size distribution have been performed inde-
pendently, with conflictual results (Simons, 2016b; Martincorena et al., 2016). Here we develop
the mathematical population genetics theory necessary to combine these approaches and explore
how the inter-individual measure of selection at a locus as provided by dN/dS values, is related to
the underlying cell population dynamics that generate intra-individual clone size distributions. This
approach naturally accounts for the nuances in somatic evolution that can make the interpretation of
dN/dS difficult. We show how this unified approach allows for greater insight into patterns of selec-
tion than either method in isolation, and importantly reveal the precise mathematical relationship
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between dN/dS values and selective coefficients in somatic evolution. We use this approach to infer
the selective advantage of mutations in normal tissue.
Results
A general approach to integrate dN/dS and clone size distributions
We present a general mathematical framework for the interpretation of frequency-dependent dN/dS
values in somatic evolution. First, we construct null models of the evolutionary dynamics in the
absence of selection, and then augment these models to incorporate the consequences of selection.
Evolutionary dynamics differ between normal tissues and cancer cells: in normal tissues maintained
by stem cells, the long-term population dynamics is controlled by an approximately fixed-size set of
equipotent stem cells undergoing a process of neutral competition (Klein and Simons, 2011),
whereas in tumour growth the overall population increases over time. We develop a null model to
predict the expected genetic diversity in the population in the absence of selection. Positive selec-
tion causes selected variants to rise to higher frequency than expected under neutral evolution
(Figure 1a), and negative selection has the opposite effect. This insight guides how we model the
effects of selection, namely the diversity of non-synonymous mutations.
Specifically, we defined the function g ; ; s; fð Þ as the expected number of mutations with selec-
tive (dis)advantage s found at a frequency f , for a given evolutionary dynamics scenario, where
mutations accumulate at a rate m per division. For the remainder of the paper we use passenger
mutations to refer to those mutations that have no functional effect (s=0) and driver mutations those
that have s>0. When comparing to data, driver mutations are taken as equivalent to non-synony-
mous mutations and passengers equivalent to synonymous mutations.
The functional form of g ; ; s; fð Þ encapsulates the population dynamics of the system with
parameter vector , which may, for example, include the growth rate of a tumour, or loss replace-
ment rate of stem cells in normal tissue. The direct interpretation of s depends on the system under
question. Following the logic of the effect of selection above, for s
0
>s we have that:
g ;; s
0
; f
 
>gð;; s; f Þ
Since dN/dS measures the excess or deficiency of mutations due to selection, taking the ratio of
g ;; s; fð Þ when s 6¼ 0 to s¼ 0 and normalizing for the mutation rates, which may differ for passenger
(p) and driver (d) mutations respectively, informs how dN/dS is expected to change as a function
of the frequency f of mutations in the population (Equation 1).
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Figure 1. dN/dS in somatic evolution depends on the frequency of clones. (a) Variants under positive selection are enriched at high frequency, this
means dN/dS estimates are dependent on the frequency of mutation, (b). The strength of selection influences the degree to which positively selected
variants are enriched at high frequencies (c).
The online version of this article includes the following figure supplement(s) for figure 1:
Figure supplement 1. Global dN/dS values in different frequency bins for patient PD31182 showing that the values depend on the frequency of
mutations.
Williams et al. eLife 2020;9:e48714. DOI: https://doi.org/10.7554/eLife.48714 3 of 19
Research article Computational and Systems Biology Genetics and Genomics
dN
dS
¼
p
d
g ;d; s; fð Þ
g ;p; s¼ 0; f
   (1)
We discuss the general properties of this model. Firstly, when s¼ 0 (neutral evolution), and pro-
vided that the mutation rates are correctly normalised, the numerator and denominator are equal
resulting in dN
dS
¼ 1, as expected. Secondly, dN/dS increases as a function of frequency f (clone size)
for positive selection, and decreases as a function of f for negative selection (Figure 1b), for all
g ;; s; fð Þ that we explored. Thirdly, the shape of the curves predicted by the underlying population
model encodes the value of the selection coefficient; for example the steepness of the increase is
proportional to the selection coefficient s (Figure 1c). These observations are a natural consequence
of positive selection driving selected mutations to higher frequency (Figure 1a).
Unfortunately, directly using Equation (1) to measure selective coefficients from the slope of the
dN/dS curve as function of frequency is often impractical. Real sequencing data often suffers from a
limited number of mutations detected at any particular frequency and measurement uncertainties in
these frequencies. To circumvent these issues, we introduce ‘interval dN/dS’ (i-dN/dS) that aggre-
gates over a frequency range to reduce the influence of these sources of noise. Interval dN/dS is
defined as:
i
dN
dS
¼
p
d
R fmax
fmin
g ;d; s; fð ÞdfR fmax
fmin
g ;p; s¼ 0; f
  
df
(2)
Fixing the integration range fmin; fmax½  allows for robust inference of s in potentially sparse and
noisy sequencing data using maximum likelihood methods (see Materials and methods).
Frequency-dependent dN/dS values in stem cell populations
In healthy tissue, only mutations that are acquired in the stem cells will persist over long times, and
so we restrict our attention to these cells. Quantitative analysis of lineage tracing data has shown
that the stem cell dynamics of many tissues conform to a process of population asymmetry
(Klein and Simons, 2011). In this paradigm, under homeostasis, the loss of stem cells through differ-
entiation is compensated by the replication of a neighbouring stem cell, thus maintaining an approx-
imately constant number of stem cells. These dynamics are represented by the rate equations:
SC !
2rl SCþ SC
DþD
p¼ 1þDð Þ=2
p¼ 1 Dð Þ=2

(3)
where SC refers to a single stem cell which divides symmetrically to produce either two stem cells or
two differentiated cells (denoted as D above), l is the rate of cell division per unit time, and r is the
probability of a symmetric divisions. The product rl is referred to as the loss/replacement rate. Dif-
ferentiated cells will ultimately be lost from the population over long time scales. Under homeosta-
sis, loss and replacement should be exactly balanced, so D = 0. With D 6¼ 0, the fate of a stem cell is
‘biased’, introducing positive or negative selection into the model. Previous mathematical analysis
shows that this model is a good description of the clonal dynamics in the oesophagus and skin
(Klein et al., 2010; Doupe´ et al., 2012; Alcolea et al., 2014). Using previous analytical results
describing the temporal evolution of the clone size distribution (see methods for detailed discussion)
we derive the frequency distribution g ;; s;Að Þ for oesophagus and skin as (Simons, 2016a;
Klein et al., 2010; Nicholson and Antal, 2016):
g ;; s;Að Þ ¼
n0
rlA
e
  A
N tð Þ (4)
Where A is the area of the clone,  is density of stem cells per mm2, n0 is the starting population
size and m the mutation rate, which may be different for drivers ðs>0Þ and passenger mutations
ðs¼ 0Þ, ie drivers and passengers may accumulate at different rates. N tð Þ is a scaling factor that
depends on D, the bias toward self-renewal, which we interpret as our selection coefficient in this
system. Specifically:
ND¼0 tð Þ ¼ 1þ rlt (5)
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ND tð Þ ¼
1þDð Þe2rlDt   1 Dð Þ
2D
(6)
N tð Þ can be interpreted as the average size of a labelled clone after time t, which even under
homeostasis grows over time and compensates for some clones being lost due to drift. From these
expressions, we can then write down an expression for i-dN/dS as a function of clone frequency (see
Materials and methods) that allows for maximum likelihood estimation of parameter values (D). We
confirmed the accuracy of our derivation using simulations (Figure 2a), and performed power calcu-
lations to determine the minimum number of mutations required to correctly infer the underlying
population dynamics: we determined that 8 mutations per gene was sufficient to accurately recover
D (Figure 2b) with accuracy increasing for higher mutation burdens (Figure 2c). We also performed
simulations where D was itself a random variable, simulating the effect of different sites within the
gene having different fitness effects. We assumed D was exponentially distributed and generated
500 simulated cohorts. Fitting i-dN/dS demonstrated that on average we infer the mean value of the
exponential distribution, Figure 2—figure supplement 1.
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Figure 2. Theoretical model of interval dN-dS fitted to simulated data and data from deep sequencing of the oesophagus. (a) Interval dN/dS as a
function of clone area for 2 simulated cohorts where driver mutations induce different biases, theoretical model captures the dynamics well and enables
us to recover the bias D, accurately. As the number of mutations increases ability to recover the correct D and the model fit (measured using R2)
improves (b) and (c). (d) Data and model fit for all neutral genes, shows i-dN/dS = 1 across the frequency range and inferred bias of 0. Data and model
fit for (e) NOTCH1 missense mutations in patient PD31182, (f) missense TP53 mutations in PD30273 and NOTCH1 nonsense mutations in PD31182 (g).
Data are black points and model fits are solid lines with shaded areas denoting 95% CI.
The online version of this article includes the following figure supplement(s) for figure 2:
Figure supplement 1. Histogram of inferred D values from simulations using an exponentially distributed fitness effect.
Figure supplement 2. Model fits for all patients in the oesophagus data set.
Figure supplement 3. Inferred biases for for each patient in the oesophagus dataset based on missense, (a) and nonsense mutations, (b).
Figure supplement 4. Individual fits for each gene in each patient in the oesophagus dataset.
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Selection advantages in histopathologically-normal human oesophagus
We inferred the selective advantage of driver mutations in human oesophagus using published deep
sequencing data from Martincorena and colleagues (Martincorena et al., 2018) that documents the
clonal expansion of a panel of putative driver mutations in histopathologically-normal oesophageal
biopsies.
We used the dndscv bioinformatics tool (Martincorena et al., 2017) to calculate frequency-
dependent dN/dS values from these data (clone size measured in fraction of mutant reads multiplied
by 2 mm2 – the area of the biopsy – and assuming 5000 stem cells per mm2 (Eyre-Walker and
Keightley, 2007) tissue). dN/dS values varied considerably as a function of mutation area (Figure 1—
figure supplement 1).
We considered the average frequency-dependent dN/dS values simultaneously across all genes
in the panel, on a patient-by-patient basis. Our theoretical model of i-dN/dS calculated from these
data fitted strikingly well (Figure 2—figure supplement 2). Estimates of the loss/replacement rate
rl of the stem cell population were in the range 1.2-5.0 per year (Figure 2—figure supplements 2
and 3). Inference of the selective advantage s (measured in terms of the bias towards self renewal D)
revealed an average bias of 0.004 (0.002 – 0.005 95% CI) per missense mutation (Figure 2—figure
supplement 3). Nonsense mutations caused a five-fold greater bias towards self-renewal of 0.021
(0.008 – 0.032 95% CI) (Figure 2—figure supplement 3). After removal of all genes that are strongly
selected, global dN/dS values on the remaining 48 genes show dN/dS of approximately 1 across the
frequency range (Figure 2d), and i-dN/dS analysis revealed that these somatic mutations do not
associate with a proliferative bias (D=0).
We then fitted the data on a gene-by-gene and patient-by-patient basis for cases where sufficient
mutations were available to perform the fit (Figure 2e–g; Figure 2—figure supplement 4). A broad
range of selective advantages were inferred (Figure 3 and Figure 3—figure supplement 1). Muta-
tions in TP53 showed large biases across all patients for both missense, D = 0.057 (0.05–0.068 95%
CI) and nonsense mutations, D = 0.094 (0.091–0.097 95% CI) (Figure 3a–b). This was also true for
mutations in NOTCH1 with D = 0.029 (0.019–0.036 95% CI) for missense and D = 0.072 (0.034–0.089
95% CI) for nonsense mutations. NOTCH2, PIK3CA, CREBBP and FAT1 also showed a bias toward
self-proliferation in multiple patients (Figure 3a–b), though most had a small effect on fitness (range
0.003–0.029 for missense mutations and 0.030–0.041 for nonsense mutations). Together these data
suggest a distribution of fitness effects (DFE) characterized by many small effect mutations with few
large effect mutations (Figure 3c–d), as is seen in organismal evolution (Eyre-Walker and Keightley,
2007). We recognize that there may be intra-gene variation of selection coefficients, that is, some
sites within genes may have stronger fitness effects than others. This is supported by clustering of
mutations within particular domains and hotspots of mutations as documented in the original study
(Martincorena et al., 2018). In future, larger cohorts and methods to estimate site level dN/dS val-
ues would allow this approach to be extended to the site level.
As our model assumes that clones emerge and expand independently we checked that the data
is not overly influenced by hitchhiking mutations,which would violate these assumptions. For this, we
leveraged the spatial sampling of tissue pieces. Approximately 90 patches were sampled from each
patient. We reasoned that patches with selected clones might be expected to have more hitchhiking
mutations, and for those mutations to be at a higher frequency when compared to patches without
selected clones. To test this hypothesis, we counted the number of non-synonymous NOTCH1 and
TP53 mutations and the number of synonymous mutations in each patch. If the synonymous muta-
tions we observe in the data are largely due to hitchhiking effects we would expect the number and
size of synonymous variants to correlate with the number of driver mutations per patch. While there
=was a statistically significant correlation for both NOTCH1 (linear regression, p<0.001) and TP53
mutations (p=0.031), the effect was small (Figure 5—figure supplement 1): for each additional
driver there was on average 0.05 additional synonymous variants (0.047 for NOTCH1 and 0.056 for
TP53). We note too that the correlation was very noisy (R2 < 0.02) and we observed no statistically
significant relationship between VAF of synonymous mutations and the number of
TP53 or NOTCH1 mutations (linear regression, p>0.1). This analysis suggests that the majority of
synonymous mutations are not hitchhikers, and consequently that assuming the independence of
clones isreasonable.
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Driver mutation selective advantage in normal skin
Martincorena and colleagues had also published data on the expansion of driver mutations in osten-
sibly normal human skin (Martincorena et al., 2015). Analyses of these data with interval dN/dS
revealed a per-patient average selective advantage per mutation (again measured in terms of the
bias towards self renewal) of D = 0.001 for missense mutations and four-fold higher (D = 0.004) for
nonsense mutations (Figure 4a-c). Performing the analysis on a gene-by-gene basis was limited by
the lower number of detected mutations, and the limited frequency range (clone size range) com-
pared to the oesophagus dataset. Good fits to the data were obtainable for NOTCH1 missense
mutations in patient PD18003 with fitness estimated to be D = 0.0149 (0.0148-0.0150 95% CI), and
TP53 missense mutations also in patient PD18003, D = 0.0054 (0.0051-0.0058 95% CI) Figure 4.
These fitness coefficients were similar to the oesophagus data. For missense mutations we were also
able to produce the distribution of fitness effects across the skin cohort, which showed similar
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Figure 3. Summary of model fits across all patients for normal oesophagus data. Inferred biases D for genes where at least 2 patients had good model
fits (R2 > 0.6 & >7 mutations) for missense mutations (a), and nonsense mutations (b). Inferred distribution of fitness effects for all genes across all
patients for missense mutations (c), and nonsense mutations (d).
The online version of this article includes the following figure supplement(s) for figure 3:
Figure supplement 1. Inferred parameters for each gene in each patient in the oesophagus dataset where there were sufficient mutations to perform
the analysis.
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characteristics to the oesophagus data of a small number of high effect mutations and a larger num-
ber of smaller effect mutations, Figure 4f.
Site frequency spectra
We next sought to challenge our model by directly fitting the site frequency spectra across ages,
taking a similar approach to studies of the blood (Watson et al., 2019), colon (Lopez-Garcia et al.,
2010), skin (Simons, 2016a) and other tissues (Klein and Simons, 2011). Our model of stem cell
dynamics makes predictions on the properties of these distributions as a function of the age of
donors. In particular, Equations (5) and (6) predict that the characteristic frequency N(t) increases
exponentially for non-neutral mutations and linearly for neutral mutations as a function of time. Plot-
ting the distribution of clone size areas showed a widening of the distribution as a function of age,
which was particularly striking for mutations in the NOTCH1 and TP53 genes, consistent with these
genes conferring large selective advantages (Figure 5a).
To quantitively test the predictions of the model and to infer parameters of interest we imple-
mented a Bayesian non-linear fitting method (see methods) to fit the following model:
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the cohort. There were insufficient nonsense mutations in the majority of genes to draw the equivalent plot for nonsense mutations.
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y¼
a
A
e
  A
exp bð Þ (7)
With the parameters a¼ n0=rl, and b¼ log N tð Þ=ð Þ to be estimated. We first validated that the
approach could correctly infer known parameters from synthetic data generated from our simulation
framework, Figure 5—figure supplement 2. Next, we fitted the model to the oesophagus dataset,
separately for non-synonymous and synonymous mutations and across ages, Figure 5e. Posterior
estimates of the compound parameter n0=rl showed consistent estimates for both non-synony-
mous and synonymous mutations (taking into account the approximate 3:1 ratio of mutable sites),
Figure 5c. Unfortunately decoupling n0=rl directly from the data is not possible and requires
independent estimates of either the mutation rate or number of stem cells. Posterior estimates of
the characteristic frequency N(t) showed an increase as a function of age for non-synonymous muta-
tions and a more modest increase for synonymous as would be predicted from theory, Figure 5d.
As another challenge to the proposed model, we also fitted the following two models which are
simpler subsets of the full model we derive theoretically, thus testing two alternate decay functions.
y¼
a
A
y¼ ae 
A
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Figure 5. Directly fitting site frequency specta supports interval dN/dS inferences. (a) Site frequency spectra become wider for older donors, with
increases in the median clone area which is more pronounced for mutations in TP53 and NOTCH1. (b) Using WAIC to perform model selection, we
found a model with an exponential term and a power law to be the best fitting model (lowest WAIC). (c) Posterior parameter estimates for n0. (d). The
characteristic frequency N tð Þ=, Interval represent 66% and 95% credible intervals respectively. (e) Site frequency spectra from data (black dots) and
posterior predictive fits for 50, 80% and 95% credible intervals (blue ribbons) for non-synonymous mutations in each don or.
The online version of this article includes the following figure supplement(s) for figure 5:
Figure supplement 1. The number of synonymous mutations as a function of the number of NOTCH1 (a) and TP53 (b) mutations per tissue piece.
Figure supplement 2. Inferring parameters from the site frequency spectrum of a simulated dataset.
Figure supplement 3. Site frequency spectra fits for NOTCH1 and TP53 non-synonymous mutations, (a).
Figure supplement 4. Regression of clone size against age.
Figure supplement 5. Comparison of results using dndscv and SSB-dN/dS.
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Here, a and b are parameters to be estimated. Comparison of the fits using the widely applicable
information criteria, WAIC (a generalized version of information criteria such as AIC and BIC) found
that our theoretical model with an exponential term and a power law term (Equation 7) provided
the best predictive accuracy (lowest WAIC), Figure 5b. Bayes factors for the proposed theoretical
model also strongly supported this as the best model (BF > 103 for both models).
We also attempted to fit the model on a gene by gene basis. However due to the limited data
points at the gene level we found that our posterior estimates for the parameters were very wide,
precluding further insight from the site frequency spectrum at the gene level, Figure 5—figure sup-
plement 3. This reveals one of the strengths of our i-dN/dS approach, which by leveraging informa-
tion across genes to infer the background mutation model and integrating over clone sizes we can
perform the inference with a limited number of data points. As an alternative to fitting the full clone
size distribution, we performed a Bayesian multi-level regression to assess which mutations showed
the largest increase in clone size as a function of age. This analysis revealed that TP53 and NOTCH1
had the largest regression coefficients, consistent with these genes having the largest selection
coefficients, Figure 5—figure supplement 4, providing qualitative support for our approach. Our
inferred selection coefficients from i-dN/dS were also correlated with the regression coefficients
from the statistical model (linear regression, p=0.004, R2 = 0.47). Taken together, analysis of the site
frequency spectrum on a patient by patient basis and a gene level statistical model are consistent
with our inferences from i-dN/dS. We find that the proposed model provides the best fit to data
when compared to other similar models, that the characteristic frequency of non-synonymous muta-
tions increases rapidly with age and that NOTCH1 and TP53 exhibit the largest increase in clone size
as a function of age.
Discussion
Here we have shown that the combination of dN/dS values with mutation frequency-based informa-
tion provides additional quantitative insight into dynamics of somatic evolution than either method
alone. Specifically, the combined approach enables direct inference of the selection coefficients of
mutations in somatic tissues. We note that our study also shows that the magnitude of the selection
coefficient is not necessarily represented by simply calculating a ‘point estimate’ of dN/dS that
neglects mutation subclonal frequency information.
Using this methodology, we have begun the construction of the distribution of fitness effects
(DFE) in somatic evolution, observing a distribution where most mutations that we analysed were
near-neutral, with a tail of highly selected variants. In both skin and oesophagus, the most highly
selected mutant genes were NOTCH1 and TP53 (increased proliferative bias of >1% and>5%
respectively). We observed that values of selective coefficients of individual genes varies between
patients, likely because of inter-patient difference in the precise location of point mutations, but
potentially also because of inter-patient variation in selective pressure from the microenvironment.
Nevertheless, the comparative rank of per-gene fitness coefficients was broadly consistent across
patients (e.g. for missense mutations across patients, TP53 mutations always had the highest fitness,
followed by NOTCH1 mutations). This consistency in selective coefficients is in agreement with the
observation of highly recurrent gene mutations in cancer (Lawrence et al., 2013) and evidence of
repeatability in cancer evolution (Caravagna et al., 2018).
Non-synonymous NOTCH1 mutations were observed approximately 3-fold more frequently that
non-synonymous TP53 mutations in oesophagus, and approximately 5-fold more frequently in skin,
suggesting that the mutation rate of NOTCH1 is greater than for TP53. Coupling these data with
our quantitative measurements of the fitness coefficients leads to the prediction that the oesopha-
gus will become transiently repopulated by NOTCH1-mutant cells during ageing, before subsequent
replacement by fitter mutant-TP53 clones.
On a cautionary note, our theoretical work shows that the clonality of mutations strongly deter-
mine the observed value of dN/dS, and so a misleading picture of the selective forces will be pro-
duced if dN/dS frequency-dependent effects are not corrected for. The accuracy of any estimate of
evolutionary dynamics from dN/dS values is of course dependent on the underlying accuracy of the
dN/dS measure itself, which is compromised by uncharacterised variability in the mutation rate
across the genome (Van den Eynden and Larsson, 2017) and in the uncertain pathogenicity of indi-
vidual single nucleotide variants (extensions to estimate site level selection coefficients may
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circumvent some of these issues [Cannataro et al., 2018; Temko et al., 2018]). We also recognize
that our model assumes a well-mixed population, while the data used in our study is from spatially
structured epithelia. Spatial structure influences the distribution of clone sizes. Effects include: the
influence of the boundary that enable rapid growth of mutants on the expanding front and con-
versely ‘encapsulation’ within a growing mass that slows clone growth (Fusco et al., 2016;
Chkhaidze et al., 2019), and clonal interference that slows the growth of two similarly fit competing
clones (Martens et al., 2011; Hall et al., 2019).
Combining population genetics methods with comparative genomics is a powerful way to infer
selection pressures in human somatic evolution, giving new insight into the fundamental parameters
that determine evolutionary dynamics in health and disease.
Materials and methods
Oesophagus and skin data
For the oesophagus and skin data we used mutation calls provided by the original studies. In the
oesophagus data when a mutation was present in multiple adjacent biopsies we used the sum of the
mutation frequency times the area of the biopsies (2 mm2) as our readout of clone size and per-
formed the dN/dS analysis on a patient by patient basis.
dN/dS calculations
For calculating dN/dS ratios the dndscv R package was used, which calculates both global dN/dS
ratios across the whole exome or a panel of genes as well as per gene dN/dS ratios using a covariate
based model to infer dN/dS values with a limited number of mutations (Martincorena et al., 2017).
We used the default settings of dndscv, using the default hg19 transcript reference provided by the
package. dndscv can also take into account small insertions and deletions, which we included in our
analysis. Therefore, where we refer to mutation this includes indels in addition to SNVs.
To calculate the interval dN/dS measure we took the clone size measurements and determined a
low cutoff fmin based on the minimum clone size. We then created a vector of clone sizes that cov-
ered the total range and calculated dN/dS between fmin and all values of fmax. This allowed us to plot
dN/dS as a function of fmax and fit our interval dN/dS models. In our data, clone size is measured in
units of area (mm2).
Accurately estimating dN/dS from sequencing data of somatic tissues can be challenging due to
the strong sequence context dependence of mutations and variability of mutation rates across the
genome. To confirm our inferences were not dependent on the choice of dN/dS methodology we
calculated dN/dS values using SSB-dNdS and then fitted our model (Zapata et al., 2018). As SSB-
dNdS only uses SNVs, we reran dndscv after removing indels. Inferences on a patient by patient
basis were highly consistent between the methods, see Figure 5—figure supplement 4. There was
more variability at the gene level, perhaps due to differences in the approaches used to control for
variability in mutation rates across the genome.
Model fitting
We used a maximum likelihood approach to fit our models to the data. Defining the observed inter-
val dN/dS as y and the model dN/dS as y^ ð Þ ¼
p
d
R fmax
fmin
g ;d ;s;fð ÞdfR fmax
fmin
g ;p ;s¼0;fð Þdf
. First of all we define the residuals
between the data and the model as R ¼ y  y^ ð Þ. Assuming that the residuals are normally distrib-
uted with mean 0 we can write down the negative log likelihood (NLL) as
NLL ð Þ ¼ 
X
y y^ ð Þ
logN y  y^ ð Þ;¼ 0; sð Þ
where N denotes the normal probability density function. We can then find the parameters  that
minimize the NLL and calculate confidence intervals on these estimates using the Fisher information
matrix. When fitting to data we ensured that there were a minimum of 8 mutations and only included
model fits with R2 > 0.6 for downstream analysis. We used a maximum likelihood approach over a
Bayesian approach to fit the model because the integral of the clone size distribution does not have
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a closed form solution, making it unfeasible to use readily available MCMC samplers which we adopt
later.
Interval dN/dS model
For the stem cell model, using Equations 2, 3, 4, 5, 6 in the main text, interval dN/dS is given by:
i
dN
dS
¼
1
1þD
Ei  
Amax
ND tð Þ
 
 Ei  
Amin
ND tð Þ
 
þ 1
2
e
 
Amax
ND tð Þ
Amax
þ e
 
Amin
ND tð Þ
Amin
  
Ei  
Amax
N tð Þ
 
 Ei  
Amax
N tð Þ
 
þ 1
2
e
 
Amax
N tð Þ
Amax
þ e
 
Amin
N tð Þ
Amin
  
Where Ei is the exponential integral Ei xð Þ ¼ 
R
¥
x
e n
n
dn.  is density of stem cells per mm2, which
we set to 5,000 cells /mm2 for fitting (Hall et al., 2019).
Simulations
To confirm the accuracy of our analytical model and investigate the influence of uncertainty in muta-
tion frequencies due to sequencing noise and to challenge some of the underlying assumptions of
our theoretical approach, we developed a simulation based model.
We seed a population of Ns stem cells that then undergo loss/replacement as described by the
following rate equations
SC !
2rl SCþ SC
DþD
p¼ 1þDð Þ=2
p¼ 1 Dð Þ=2

As only the stem cells are long lived the differentiated cells are not explicitly modelled such that
when a stem cell ’differentiates’ it is effectively lost from the population. During division, daughter
cells acquire mutations with a fitness effect at rate d and passenger mutations at rate p. Fitness
increases the bias toward self-proliferation D of a stem cell lineage. Additional driver mutations do
not further increase the fitness of stem cells.
To calculate dN/dS across a cohort of tissue biopsies we count the number of driver mutations Nd
and the number of passenger mutations, Np and then normalize by their respective mutation rates.
In our model drivers = non-synonymous and thus every driver has an effect on fitness. Then the ratio
of these two numbers gives us the excess or deficit of mutations due to selection – ie the dN/dS
ratio.
dN
dS
¼
Nd=d
Np=p
For the interval dN/dS we simply calculate the Nx between fmin and fmax.
To introduce uncertainty into mutation frequencies we perform a process of empirically motivated
sampling to the true underlying frequency f . Firstly, we specify the average depth of sequencing D,
then the depth of sequencing for mutation i is given by
Di ¼ Poisson Dð Þ
The sampled number of read counts is then
ns ¼ Binomial n¼Di; p¼ fð Þ
And the sampled variant frequency is then fs ¼ ns=Di.
The simulation framework was written in Julia (Bezanson et al., 2017) and is available at https://
github.com/marcjwilliams1/StemCellModels.jl.
Fitting site frequency spectra
To fit the site frequency spectra we first removed mutations with clone size area < 0.008. This cutoff
was determined by inspection of the point of highest density of the clone size area histograms, rea-
soning that below this frequency the data was limited due to the resolution of the sequencing assay.
We then binned the data using a bin size of 0.005 and counted the number of mutations in each bin.
We did this for each donor and separately for non-synonymous and synonymous mutations. We then
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used the brms (Bayesian Regression Modeling with Stan) R package (Bu¨rkner, 2017) to fit the fol-
lowing non-linear model jointly across all patients:
C¼
a
A
e
  A
exp bð Þ
With the parameters a¼ n0
rl, and b¼ log N tð Þð Þ to be estimated and C being the number of muta-
tions and A the area. We used the following priors for the parameters:
A~Normal 5;2ð Þ
B~Normal 0; 5ð Þ
We ran 4 chains with 5000 iterations with the first 2500 used as warmup. To assess convergence
we ensured that the scale reduction factor R^ (a measure of mixing of chains) was < 1.01 as
recommended.
We also fitted the following two models:
C¼
a
A
C¼ ae 
A
exp bð Þ
We used the same prior distributions as above. We then compared the predictive accuracy of the
different models using the widely applicable information criteria (WAIC) (Vehtari et al., 2017). This
found that the functional form derived from theory provided the best fit, Figure 5b. Bayes factors to
compare models were calculated using the bayestestR package (Makowski et al., 2019). The log10
(BF) of the proposed theoretical model vs the power law was 52 and 44 when compared against the
exponential model.
Bayesian multi-level regression
We performed a Bayesian multi-level regression of clone size ~ age with the gene as a random
effect. This allowed us to determine which genes cause the largest increase in frequency as a func-
tion of age. This was done using brms in R with default priors, 4 chains and 5000 iterations. Using
R’s statistical modelling syntax the model is given by clone size ~age + (1 + age|gene). We fit the
model assuming a normal distribution as well as a log-normal distribution, finding the latter to pro-
vide the best predictive accuracy (lowest WAIC) and superior posterior predictive check.
Site frequency spectra for a model of stem cell proliferation
Our mathematical model of stem cell proliferation drew on results from a range of studies analysing
the clone size distribution from lineage tracing experiments. Particularly useful are the results from
Klein et al. (2010), which we took as a starting point for our model. We follow the notation used in
this study to a large extent. Other studies that are also illuminating and relevant are the theoretical
work of Nicholson and Antal (2016), while similar theoretical models have also been applied to the
oesophagus (Doupe´ et al., 2012), airway epithelia (Teixeira et al., 2013) and the blood
(Watson et al., 2019) amongst others. In this section we outline the key results relevant to our
approach.
We begin with the set of rate equations presented in the main text:
SC !
2rl SCþ SC
DþD
p¼ 1þDð Þ=2
p¼ 1 Dð Þ=2

From this we are interested in the clone size distribution, that is, the probability of observing a
clone of size n after time t. In other fields such as population genetics, this distribution is equivalent
to the site frequency spectrum. Given the above rate equations, we can express the dynamics as a
birth-death process with birth rate b¼ rl 1þDð Þ and death rate d¼ rl 1 Dð Þ which allows us to write
down the master equation for the probability of observing a clone of size n at time t, pn.
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dpn
dt
¼ b n  1ð Þpn 1  bþ dð Þnpnþ d nþ 1ð Þpnþ1
dp0
dt
¼ dp1
This has the following solution (see Bailey, 1990 p92)
pn tð Þ ¼ 1 a tð Þð Þ 1 b tð Þð Þb tð Þ
n 1
p0 tð Þ ¼ a tð Þ
With a tð Þ and b tð Þ defined as follows:
a tð Þ ¼
d e b dð Þt   1
  
be b dð Þt   d
b tð Þ ¼
b e b dð Þt   1
  
be b dð Þt   d
From these results we can obtain the average size of surviving clones, N tð Þ:
N tð Þ ¼
X¥
n¼0
n
pn
1  p0
¼
1
1 b tð Þ
¼
1þDð Þe2rlDt   1 Dð Þ
2D
Which, as will become apparent, gives a characteristic scale for the distribution.
Thus far we have only considered a single mutant at time 0, while we are interested in the case
when mutants continually enter the population at a rate n0 where m is the mutation rate per cell
division and n0 is the number of stem cells. To derive the clone size distribution in this case, we take
the integral over time multiplied by the mutation rate.
gn ¼
n0
rl
Z t
0
pn tð Þdt¼
n0
rln
b tð Þn
We can approximate b tð Þn¼ 1  1=N tð Þð Þn »e 
n
N tð Þ which gives
gn »
n0
rln
e
  n
N tð Þ
The data we make use of doesn’t provide integer clone sizes but rather area of clones, so we can
make the transformation n¼ A:
gA tð Þ»
n0
rlA
e
  A
N tð Þ
This is the result presented in the main text.
Code and data availability
Code to reproduce all the figures in the manuscript (using a snakemake [Ko¨ster and Rahmann,
2012] workflow) is available at github.com/marcjwilliams1/dnds-clonesize (Williams, 2020; copy
archived at https://elifesciences-publications/dnds-clonesize). We also created a singularity image
with all software dependencies which is available at shub://marcjwilliams1/dnds-clonesize-R-con-
tainer. Julia (Bezanson et al., 2017) was used for the simulations and R (R Development Core
Team, 2019) was used to analyse the data and generate the figures. Some of the analysis rely in
bespoke packages written for this study which are freely available under an open source licence.
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Data availability
No new data was generated in this; only previously published data is reanalysed. Computer code
implementing the new mathematical theory we developed is available here: https://github.com/
marcjwilliams1/dnds-clonesize (copy archived at https://github.com/elifesciences-publications/dnds-
clonesize).
The following previously published datasets were used:
Author(s) Year Dataset title Dataset URL
Database and
Identifier
Martincorena I,
Fowler JC Wabik A,
Lawson AAR,
Abascal F, Michael
Hall WJ, Cagan A,
Murai k, Mahbubani
K, Stratton MR,
Fitzgerald RC,
Handford PA,
Campbell PJ, Saeb-
Parsy K, Jones PH
2018 EGAD00001004158 https://www.ebi.ac.uk/
ega/datasets/
EGAD00001004158
European Genome-
phenome Archive,
EGAD00001004158
Martincorena I,
Fowler JC Wabik A,
Lawson AAR,
Abascal F, Michael
Hall WJ, Cagan A,
Murai k, Mahbubani
K, Stratton MR,
Fitzgerald RC,
Handford PA,
Campbell PJ, Saeb-
Parsy K, Jones PH
2018 EGAD00001004159 https://www.ebi.ac.uk/
ega/datasets/
EGAD00001004159
European Genome-
phenome Archive,
EGAD0000100
4159
Martincorena I,
Roshan A, Ger-
stung M, Ellis P,
Van Loo P, McLaren
S, Wedge DC,
Fullam A, Alexan-
drov LB, Tubio JM,
Stebbings L, Men-
zies A, Widaa S,
Stratton MR, Jones
PH, Campbell PJ
2016 EGAS00001000860 https://www.ebi.ac.uk/
ega/datasets/EGA
S00001000860
European Genome-
phenome Archive,
EGAS00001000860
Martincorena I,
Roshan A, Ger-
stung M, Ellis P,
Van Loo P, McLaren
S, Wedge DC,
Fullam A, Alexan-
drov LB, Tubio JM,
Stebbings L, Men-
zies A, Widaa S,
Stratton MR, Jones
PH, Campbell PJ
2016 EGAS00001000515 https://www.ebi.ac.uk/
ega/datasets/EGA
S00001000515
European Genome-
phenome Archive,
EGAS00001000515
Martincorena I,
Roshan A, Ger-
stung M, Ellis P,
Van Loo P, McLaren
S, Wedge DC,
Fullam A, Alexan-
drov LB, Tubio JM,
Stebbings L, Men-
zies A, Widaa S,
Stratton MR, Jones
PH, Campbell PJ
2016 EGAS00001000603 https://www.ebi.ac.uk/
ega/datasets/EGA
S00001000603
European Genome-
phenome Archive,
EGAS00001000603
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